Scoring system for optimal cord blood unit selection for single cord blood transplantation

脐带血 川地34 医学 移植 内科学 骨髓 免疫学 人类白细胞抗原 男科 干细胞 胃肠病学 生物 抗原 遗传学
作者
Mizuki Watanabe,Takaaki Konuma,Nobuhiko Imahashi,Seitaro Terakura,Sachiko Seo,Satoko Morishima,Naoyuki Uchida,Noriko Doki,Masatsugu Tanaka,Tetsuya Nishida,Toshiro Kawakita,Tetsuya Eto,Satoshi Takahashi,Masashi Sawa,Yasufumi Uehara,Sung‐Won Kim,Fumihiko Ishimaru,Tatsuo Ichinohe,Takahiro Fukuda,Yoshiko Atsuta,Junya Kanda
出处
期刊:Cytotherapy [Elsevier BV]
卷期号:26 (3): 286-298
标识
DOI:10.1016/j.jcyt.2023.12.001
摘要

We conducted a retrospective study to categorize the cord blood unit (CBU)s to identify the optimal units.A total of 8503 adults (female, n = 3592; male, n = 4911) receiving their first single cord blood transplantation (CBT) in 2000-2019 were analyzed. Factors associated with CBUs affecting overall survival (OS) and neutrophil engraftment were selected to create ranked categorization for each outcome, followed by comparison with transplantation using HLA-matched bone marrow (BMT)/peripheral blood stem cell (PBSCT) from unrelated (n = 6052) and related donors (n = 4546).Sex-mismatch, CD34+ cell and CFU-GM counts were selected in the OS analysis. Considering the strong interaction between sex mismatch and CD34+ cell counts, we analyzed females and males separately. For females, female CBU with CD34+ cell counts {greater than or equal to} 0.5 × 10e5/kg and CFU-GM counts {greater than or equal to} 15 × 10e3/kg offered the best OS (Group I), followed by other groups with any (Groups II-IV) or all (Group V) of the risk factors. Group I consistently showed favorable OS (Group IV: HR1.22, P = 0.027; Group V: HR1.31, P = 0.047), comparable to those of rBMT/PBSCT (OS: HR1.02, P = 0.654) and uBM/PBSCT in patients with higher rDRI (HR1.07, P = 0.353). Male patients lacked significant factors affecting OS. Categorization for neutrophil engraftment consisting of CD34+ cell and CFU-GM counts, sex-mismatch, presence of donor-specific antibodies, and the number of HLA-mismatches was effective but not predicted OS.Our ranked categorizations sufficiently predicted female OS and engraftment. The best-ranked CBUs offered preferable outcomes comparable to conventional BM/PB donors in female but not in male patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
卷大喵发布了新的文献求助10
2秒前
淡然士晋发布了新的文献求助10
2秒前
三愿完成签到 ,获得积分10
2秒前
5秒前
BONe完成签到,获得积分10
7秒前
研友_CCQ_M完成签到,获得积分10
8秒前
科研通AI5应助hui采纳,获得10
8秒前
BONe发布了新的文献求助10
9秒前
TT2022发布了新的文献求助10
10秒前
赘婿应助yangching采纳,获得10
11秒前
搜集达人应助成诗怡采纳,获得10
12秒前
不甜完成签到 ,获得积分10
13秒前
13秒前
李健应助yeyii采纳,获得10
14秒前
16秒前
18秒前
18秒前
yige发布了新的文献求助10
18秒前
19秒前
淡然士晋完成签到,获得积分10
20秒前
暗月皇发布了新的文献求助10
20秒前
糊涂的元珊完成签到 ,获得积分10
20秒前
Mry完成签到,获得积分10
21秒前
哈哈哈哈嘻嘻嘻完成签到 ,获得积分10
24秒前
日出发布了新的文献求助10
24秒前
成诗怡发布了新的文献求助10
24秒前
KXC完成签到,获得积分20
24秒前
huahua完成签到 ,获得积分10
27秒前
田様应助Oasis采纳,获得10
27秒前
阳光完成签到,获得积分10
29秒前
冲冲冲完成签到,获得积分10
29秒前
暖羊羊Y完成签到 ,获得积分10
31秒前
顺其自然_666888完成签到,获得积分10
31秒前
wy1693207859完成签到,获得积分10
32秒前
邓佳鑫Alan应助芷兰丁香采纳,获得10
32秒前
成诗怡完成签到,获得积分10
33秒前
Yu完成签到,获得积分10
36秒前
渣渣凡完成签到,获得积分10
37秒前
38秒前
zhouyan完成签到,获得积分10
41秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3781110
求助须知:如何正确求助?哪些是违规求助? 3326526
关于积分的说明 10227602
捐赠科研通 3041675
什么是DOI,文献DOI怎么找? 1669552
邀请新用户注册赠送积分活动 799100
科研通“疑难数据库(出版商)”最低求助积分说明 758734